1 00:00:05,760 --> 00:00:06,800 WELCOME TO EVERYBODY ON THE 2 00:00:06,800 --> 00:00:08,720 BOARD, WELCOME TO Dr. 3 00:00:08,720 --> 00:00:09,160 BERTAGNOLLI. 4 00:00:09,160 --> 00:00:10,360 IT'S A PLEASURE TO HAVE YOU 5 00:00:10,360 --> 00:00:12,920 JOINING US THIS MORNING. 6 00:00:12,920 --> 00:00:14,360 I JUST WANT TO REMIND EVERYBODY 7 00:00:14,360 --> 00:00:16,600 ON THE BOARD THIS IS AN OPEN 8 00:00:16,600 --> 00:00:17,960 SESSION THAT WE ARE NOW CALLING 9 00:00:17,960 --> 00:00:19,720 TO ORDER. 10 00:00:19,720 --> 00:00:21,240 I ALSO WANT TO NOTE THAT MEMBERS 11 00:00:21,240 --> 00:00:23,000 OF THE PUBLIC, WHO MAY WISH TO 12 00:00:23,000 --> 00:00:24,920 EXPRESS VIEWS REGARDING ANY 13 00:00:24,920 --> 00:00:26,440 ITEMS DISCUSSED DURING THIS 14 00:00:26,440 --> 00:00:29,880 MEETING, MAY DO SO BY WRITING TO 15 00:00:29,880 --> 00:00:32,440 Dr. TONDRAVI EXECUTIVE 16 00:00:32,440 --> 00:00:33,760 SECRETARY WITHIN 10 DAYS OF THE 17 00:00:33,760 --> 00:00:34,280 MEETING. 18 00:00:34,280 --> 00:00:35,280 ANY WRITTEN STATEMENTS BY 19 00:00:35,280 --> 00:00:40,000 MEMBERS OF THE PUBLIC WILL 20 00:00:40,000 --> 00:00:41,320 RECEIVE CAREFUL CONSIDERATION 21 00:00:41,320 --> 00:00:44,400 AND WE'LL LIKE TO TURN THE FLOOR 22 00:00:44,400 --> 00:00:47,480 OVER TO Dr. MONICA 23 00:00:47,480 --> 00:00:47,880 BERTAGNOLLI. 24 00:00:47,880 --> 00:00:48,880 >>Dr. Bertagnolli: THANK YOU SO 25 00:00:48,880 --> 00:00:49,720 MUCH, ERIC. 26 00:00:49,720 --> 00:00:53,360 CAN I HAVE THE FIRST SLIDE, 27 00:00:53,360 --> 00:00:53,920 PLEASE. 28 00:00:53,920 --> 00:00:55,640 SO, I'M REALLY PLEASED TO BE 29 00:00:55,640 --> 00:00:56,680 HERE TO SPEAK TO YOU TODAY. 30 00:00:56,680 --> 00:01:01,440 THIS IS MY VERY FIRST BSE 31 00:01:01,440 --> 00:01:02,360 MIGHTING AS NCI DIRECTOR. 32 00:01:02,360 --> 00:01:04,640 THE INTRAMURAL RESEARCH PROGRAM 33 00:01:04,640 --> 00:01:08,240 IS SUCH A CRITICAL PART OF NCI'S 34 00:01:08,240 --> 00:01:08,680 MISSION. 35 00:01:08,680 --> 00:01:10,800 I HAVE TO EXPRESS MY GRATITUDE 36 00:01:10,800 --> 00:01:14,120 TO ALL OF YOU THAT WE ARE ABLE 37 00:01:14,120 --> 00:01:16,440 TO TAP INTO YOUR EXPERTISE TO 38 00:01:16,440 --> 00:01:18,360 HELP ENSURE OUR INTRAMURAL 39 00:01:18,360 --> 00:01:28,880 RESEARCH IS ON THE RIGHT PATH. 40 00:01:34,960 --> 00:01:36,320 >>Dr. BERTAGNOLLI. 41 00:01:36,320 --> 00:01:46,280 YOU ARE CUT NO CU CUTTING IN AN. 42 00:01:46,280 --> 00:01:48,440 >>YOU ARE FINE. 43 00:01:48,440 --> 00:01:49,280 WE HEAR YOU FINE. 44 00:01:49,280 --> 00:01:50,720 >>SOUNDS GOOD TO ME. 45 00:01:50,720 --> 00:01:53,400 >>SHE'S NOT CUT NORTH AND OUT 46 00:01:53,400 --> 00:01:53,680 FOR US. 47 00:01:53,680 --> 00:02:00,400 >>I'M SORRY, MY APOLOGIES. 48 00:02:00,400 --> 00:02:00,960 >>Dr. Bertagnolli: GREAT. 49 00:02:00,960 --> 00:02:02,080 YOU KNOW, I KNOW WE HAVE A LOT 50 00:02:02,080 --> 00:02:04,120 TO COVER TODAY SO I'M GOING TO 51 00:02:04,120 --> 00:02:05,840 TRY TO BE QUICK. 52 00:02:05,840 --> 00:02:07,280 I'M GOING TO TALK A LITTLE BIT 53 00:02:07,280 --> 00:02:10,320 ABOUT RECENT PROGRESS, OUR 54 00:02:10,320 --> 00:02:13,080 BUDGET, GIVE YOU A QUICK VIEW OR 55 00:02:13,080 --> 00:02:14,280 EARLY VIEW OF SOMETHING WE'RE 56 00:02:14,280 --> 00:02:16,640 CALLING THE NATIONAL CANCER PLAN 57 00:02:16,640 --> 00:02:27,080 AND SOME OVER ALL UPDATES. 58 00:02:41,560 --> 00:02:43,640 >>PRESIDENT BIDEN CONTINUED IN 59 00:02:43,640 --> 00:02:46,040 HIS STATE OF THE UNION ADDRESS, 60 00:02:46,040 --> 00:02:48,040 TO SHOW STRONG SUPPORT FOR ALL 61 00:02:48,040 --> 00:02:51,040 THAT WE SEEK TO DO. 62 00:02:51,040 --> 00:02:52,080 YOU MAY HAVE SEEN HE CONTINUED 63 00:02:52,080 --> 00:02:55,160 HIS MESSAGE THAT INTENDS TO GO 64 00:02:55,160 --> 00:02:58,120 BIG TO ACHIEVE BOLD GOALS, 65 00:02:58,120 --> 00:03:02,120 WORTHY OF COMPARISON TO THE 66 00:03:02,120 --> 00:03:03,320 MOONSHOT EFFORT THAT GOT US TO 67 00:03:03,320 --> 00:03:04,720 THE MOON IN 1969. 68 00:03:04,720 --> 00:03:07,120 HE CALLED UPON ALL US OF TO WORK 69 00:03:07,120 --> 00:03:08,800 TOGETHER TO END CANCER AS WE 70 00:03:08,800 --> 00:03:11,680 KNOW IT, TO CUT THE CANCER 71 00:03:11,680 --> 00:03:14,360 MORTALITY RATE BY 50% IN 25 72 00:03:14,360 --> 00:03:16,680 YEARS, TO TURN MORE CANCERS FROM 73 00:03:16,680 --> 00:03:18,960 DEATH SENTENCES INTO TREATABLE 74 00:03:18,960 --> 00:03:20,960 DISEASES AND TO PROVIDE MORE 75 00:03:20,960 --> 00:03:23,240 SUPPORT FOR PATIENTS AND 76 00:03:23,240 --> 00:03:23,840 FAMILIES. 77 00:03:23,840 --> 00:03:27,080 HIS SPEECH WAS VERY TOUCHING. 78 00:03:27,080 --> 00:03:31,720 HE CLEARLY MADE IT ALL OF US 79 00:03:31,720 --> 00:03:35,080 AWARE THAT OUR FOCUS IS CANCER 80 00:03:35,080 --> 00:03:37,760 PATIENTS AND THEIR FAMILIES. 81 00:03:37,760 --> 00:03:40,200 AND WE CAN NEVER FORGET THAT 82 00:03:40,200 --> 00:03:44,400 THIS IS OUR CORE MISSION. 83 00:03:44,400 --> 00:03:45,080 HAVING PRESIDENT JOE BIDEN 84 00:03:45,080 --> 00:03:49,760 BEHIND US, WE'RE VERY OPTIMISTIC 85 00:03:49,760 --> 00:03:50,400 AND NCI OVER THAT YOU WILL NOW 86 00:03:50,400 --> 00:03:53,280 IS OUR TIME TO MAKE VERY BIG 87 00:03:53,280 --> 00:03:54,480 MOVES AND BIG PROGRESS. 88 00:03:54,480 --> 00:03:57,200 NEXT SLIDE, PLEASE. 89 00:03:57,200 --> 00:03:59,800 WE GOT GOOD NEWS FROM CONGRESS 90 00:03:59,800 --> 00:04:01,000 IN DECEMBER. 91 00:04:01,000 --> 00:04:02,200 LEGISLATION WAS SIGNED BY THE 92 00:04:02,200 --> 00:04:04,720 PRESIDENT THAT PROVIDED FUNDING 93 00:04:04,720 --> 00:04:06,520 FOR NCI AND NIH AND OTHER 94 00:04:06,520 --> 00:04:09,880 FEDERAL AGENCIES THROUGH 95 00:04:09,880 --> 00:04:11,680 SEPTEMBER 30th OF THIS YEAR 96 00:04:11,680 --> 00:04:15,800 AND CONGRESS DEMONSTRATED ITS 97 00:04:15,800 --> 00:04:17,000 DEEP CONCERN FOR PEOPLE WITH 98 00:04:17,000 --> 00:04:18,800 CANCER AND STRONG SUPPORT OF OUR 99 00:04:18,800 --> 00:04:19,120 WORK. 100 00:04:19,120 --> 00:04:20,440 WE RECEIVED A TOTAL BUDGET 101 00:04:20,440 --> 00:04:25,560 INCREASE OF $408 MILLION FOR 102 00:04:25,560 --> 00:04:29,680 2023 WHICH WAS $386 MILLION AND 103 00:04:29,680 --> 00:04:31,280 $22 MILLION TO THE FINAL YEAR OF 104 00:04:31,280 --> 00:04:35,120 THE FIRST ROUND OF MOONSHOT 105 00:04:35,120 --> 00:04:36,520 FUNDING FOREL 21st CENTURY 106 00:04:36,520 --> 00:04:36,840 CURES ACT. 107 00:04:36,840 --> 00:04:41,880 WE HAVE RECEIVED A TOTAL OF 108 00:04:41,880 --> 00:04:44,080 $216 MILLION IN CANCER MOONSHOT 109 00:04:44,080 --> 00:04:45,560 FUNDING THAT YEAR. 110 00:04:45,560 --> 00:04:47,360 THIS INCREASE TODAY OUR BICE 111 00:04:47,360 --> 00:04:50,640 MAKES IT POSSIBLE TO FUND MORE 112 00:04:50,640 --> 00:04:52,480 COMPELLING INVESTIGATOR 113 00:04:52,480 --> 00:04:54,760 INITIATED RESEARCH AND TO 114 00:04:54,760 --> 00:04:59,200 CONTINUE TO SUPPORT KEY RESEARCH 115 00:04:59,200 --> 00:05:01,400 OUTSIDE OF THE RPG POOL 116 00:05:01,400 --> 00:05:02,920 INCLUDING OUR CANCER CLINICAL 117 00:05:02,920 --> 00:05:05,440 TRIALS NETWORK, CORE SUPPORT FOR 118 00:05:05,440 --> 00:05:07,800 NCI DESIGNATED CANCER CENTERS, 119 00:05:07,800 --> 00:05:12,120 TRAINING AND THE INTRAMURAL 120 00:05:12,120 --> 00:05:12,720 PROGRAMS. 121 00:05:12,720 --> 00:05:14,280 I'M VERY PLEASED TO SAY THAT 122 00:05:14,280 --> 00:05:15,560 WITH INCREASE WE WERE ABLE TO 123 00:05:15,560 --> 00:05:20,400 INCREASE THE RO1 PAYLINES TO THE 124 00:05:20,400 --> 00:05:22,520 12th PERCENTILE COMPARED TO 125 00:05:22,520 --> 00:05:27,000 11% IN 2022. 126 00:05:27,000 --> 00:05:30,440 WE WERE ALSO NOT ABLE TO 127 00:05:30,440 --> 00:05:34,280 INCREASE THE RO1s TO THE 128 00:05:34,280 --> 00:05:36,480 17th PERCENT UP FROM 16%. 129 00:05:36,480 --> 00:05:38,120 BECAUSE OF THESE PAYLINE 130 00:05:38,120 --> 00:05:40,280 INCREASES WE WERE ABLE TO FUND 131 00:05:40,280 --> 00:05:43,400 MORE THAN 100 ADDITIONAL RO1 AND 132 00:05:43,400 --> 00:05:47,080 ESI AWARDS COMPARED TO LAST 133 00:05:47,080 --> 00:05:47,960 YEAR. 134 00:05:47,960 --> 00:05:50,400 RPG FUNDING IS VERY IMPORTANT. 135 00:05:50,400 --> 00:05:52,840 IT ALLOWS INVESTIGATORS, ACROSS 136 00:05:52,840 --> 00:05:55,400 THE NATION, AND SOMETIMES THE 137 00:05:55,400 --> 00:05:57,800 WORLD, TO SUBMIT THEIR VERY BEST 138 00:05:57,800 --> 00:05:58,280 IDEAS. 139 00:05:58,280 --> 00:06:01,000 AND TURN THEIR INNOVATIVE NEW 140 00:06:01,000 --> 00:06:03,720 IDEAS INTO ANSWERS THAT DRIVE 141 00:06:03,720 --> 00:06:05,040 PROGRESS. 142 00:06:05,040 --> 00:06:07,880 ANOTHER BIG PRIORITY FOR US IS 143 00:06:07,880 --> 00:06:11,800 FUNDING CRITICAL INFRASTRUCTURE, 144 00:06:11,800 --> 00:06:12,400 INCLUDING INFORMATION 145 00:06:12,400 --> 00:06:12,720 TECHNOLOGY. 146 00:06:12,720 --> 00:06:14,720 THESE ARE THINGS THAT PROMISE TO 147 00:06:14,720 --> 00:06:17,240 AMPLIFY CANCER RESEARCH RESULTS, 148 00:06:17,240 --> 00:06:21,960 DRIVE NEW COLLABORATIONS, AND 149 00:06:21,960 --> 00:06:22,560 ENSURE MAXIMAL USE OF OUR PRIOR 150 00:06:22,560 --> 00:06:23,880 COMMENTS AND RESEARCH. 151 00:06:23,880 --> 00:06:27,000 SO WE'VE ALLOCATED NEW FUNDING 152 00:06:27,000 --> 00:06:30,720 TO MEET THESE NEEDS. 153 00:06:30,720 --> 00:06:32,400 UNFORTUNATELY, LIKE SO MUCH OF 154 00:06:32,400 --> 00:06:34,240 BIOMEDICAL RESEARCH, WE HAVEN'T 155 00:06:34,240 --> 00:06:37,280 BEEN IMMUNE TO THIS PERIOD OF 156 00:06:37,280 --> 00:06:39,600 SIGNIFICANT INFLATION. 157 00:06:39,600 --> 00:06:41,880 AS A RESULT, OUR DECISION TO 158 00:06:41,880 --> 00:06:44,480 RAISE PAY LINES AND FUND 159 00:06:44,480 --> 00:06:45,640 CRITICAL INFRASTRUCTURE ALSO 160 00:06:45,640 --> 00:06:48,880 REQUIRES COST-CUTTING ELSEWHERE. 161 00:06:48,880 --> 00:06:51,560 WE DECIDE TODAY PAY MOST 162 00:06:51,560 --> 00:06:53,640 CONTINUING, NON COMPETING GRANTS 163 00:06:53,640 --> 00:06:55,000 THAT IS YEARS TWO THROUGH FIVE 164 00:06:55,000 --> 00:06:59,440 OF A TYPICAL FIVE-YEAR GRANT AT 165 00:06:59,440 --> 00:07:00,840 95%. 166 00:07:00,840 --> 00:07:05,200 WE ALSO CONSIDERABLY TIGHTENED 167 00:07:05,200 --> 00:07:07,640 OUR BELTS AT NCI, RELEVANT TO 168 00:07:07,640 --> 00:07:09,160 THE INTRAMURAL PROGRAM. 169 00:07:09,160 --> 00:07:10,960 AFTER WE COVERED OUR INCREASED 170 00:07:10,960 --> 00:07:13,640 BASELINE COST, WE ALSO HAD OUR 171 00:07:13,640 --> 00:07:16,080 DIVISIONS, OFFICERS, AND CENTERS 172 00:07:16,080 --> 00:07:18,240 TAKE A 2% CUT. 173 00:07:18,240 --> 00:07:20,320 AS JUST AS WE ASKED OUR 174 00:07:20,320 --> 00:07:27,520 EXTRAMURAL RESEARCHERS TO DO. 175 00:07:27,520 --> 00:07:29,960 YOU MAY HAVE SEEN THIS IN OUR 176 00:07:29,960 --> 00:07:31,760 FISCAL YEAR 2024 ANNUAL PLAN AND 177 00:07:31,760 --> 00:07:32,960 IN OUR WEBSITE. 178 00:07:32,960 --> 00:07:35,120 IT SHOWS THE CHALLENGE THAT WE 179 00:07:35,120 --> 00:07:37,600 TAKE ON EVERY TIME WE RAISE THE 180 00:07:37,600 --> 00:07:38,080 PAYLINE. 181 00:07:38,080 --> 00:07:39,600 WHEN WE INCREASE THE PAYLINE 182 00:07:39,600 --> 00:07:42,240 EVERY YEAR, WE MAKE A COMMITMENT 183 00:07:42,240 --> 00:07:44,920 TO SUSTAIN THOSE GRANTS FOR AT 184 00:07:44,920 --> 00:07:46,760 LEAST FIVE YEARS. 185 00:07:46,760 --> 00:07:49,080 SO, WE ALWAYS REQUIRE ADDITIONAL 186 00:07:49,080 --> 00:07:51,440 RESOURCES IN THE OUT YEARS, YEAR 187 00:07:51,440 --> 00:07:54,440 TWO THREE FIVE, JUST TO SUSTAIN 188 00:07:54,440 --> 00:07:56,640 FUNDING AT THAT PERCENTILE 189 00:07:56,640 --> 00:07:57,320 LEVEL. 190 00:07:57,320 --> 00:08:01,080 EVEN MORE, IF WE ARE TO GO ON TO 191 00:08:01,080 --> 00:08:02,880 FURTHER INCREASE THE PAYLINE. 192 00:08:02,880 --> 00:08:04,800 LET ME JUST EMPHASIZE OUR 193 00:08:04,800 --> 00:08:08,920 PAYLINE AT 12% IS NOW THE 194 00:08:08,920 --> 00:08:15,760 HIGHEST IT HAS BEEN SINCE 2010, 195 00:08:15,760 --> 00:08:17,640 A 13 -- IT'S BEEN 13 YEARS SINCE 196 00:08:17,640 --> 00:08:20,320 THE PAYLINE HAS BEEN 12% AND 197 00:08:20,320 --> 00:08:21,600 HIGHER. 198 00:08:21,600 --> 00:08:23,880 SO, I'M SURE I'LL SEE THE 199 00:08:23,880 --> 00:08:28,080 IMPORTANCE OF THIS IN SPITE OF 200 00:08:28,080 --> 00:08:29,320 THE FACT IT INTRODUCES 201 00:08:29,320 --> 00:08:31,400 CHALLENGES FOR THE FUTURE AND IS 202 00:08:31,400 --> 00:08:33,440 ASKED FOR SOME BELT-TIGHTENING 203 00:08:33,440 --> 00:08:37,960 BOTH IN THE EXTRAMURAL AND 204 00:08:37,960 --> 00:08:41,160 INTRAMURAL COMMUNITIES. 205 00:08:41,160 --> 00:08:42,800 I WROTE ABOUT THESE BUDGET 206 00:08:42,800 --> 00:08:44,000 DECISIONS AND CHALLENGE THIS IS 207 00:08:44,000 --> 00:08:49,160 A RESENT POST ON THE NCI 208 00:08:49,160 --> 00:08:50,560 BOTTOMEL LINE BOG WHERE WE 209 00:08:50,560 --> 00:08:52,320 SHARED OUR FISCAL LANDSCAPE, 210 00:08:52,320 --> 00:08:53,480 FUNDING AND PROCESSES. 211 00:08:53,480 --> 00:08:56,400 ON A RECENT NCI CANCER CURRENT 212 00:08:56,400 --> 00:08:58,720 BLOG, I ALSO WROTE A POST THAT 213 00:08:58,720 --> 00:09:00,520 EMPHASIZES THAT THIS IS A TIME 214 00:09:00,520 --> 00:09:03,080 OF GREAT OPPORTUNITY FOR CANCER 215 00:09:03,080 --> 00:09:06,680 RESEARCH BY HIGHLIGHTING 216 00:09:06,680 --> 00:09:08,960 PROGRESS FROM DECADES OF 217 00:09:08,960 --> 00:09:09,560 INVESTMENT. 218 00:09:09,560 --> 00:09:10,760 PRESIDENT JOE BIDEN COMMITMENT 219 00:09:10,760 --> 00:09:12,320 AND IMPORTANT PROGRAMS NCI HAS 220 00:09:12,320 --> 00:09:14,080 LAUNCHED IN THE LAST YEAR. 221 00:09:14,080 --> 00:09:16,160 IN THERE, I ALSO UNDER SCORED 222 00:09:16,160 --> 00:09:21,680 THE IMPORTANCE OF THE LAST MILE. 223 00:09:21,680 --> 00:09:29,000 FROM VALIDATION OF A SUCCESSFUL 224 00:09:29,000 --> 00:09:30,760 INTERVENTION, TO THE BROAD 225 00:09:30,760 --> 00:09:31,400 IMPLEMENTATION. 226 00:09:31,400 --> 00:09:34,360 THIS REQUIRES PARTICIPATION FROM 227 00:09:34,360 --> 00:09:36,520 SO MANY OTHERS THROUGHOUT OUR 228 00:09:36,520 --> 00:09:37,240 SOCIETY. 229 00:09:37,240 --> 00:09:39,640 TO MAKE OUR RESEARCH TRULY 230 00:09:39,640 --> 00:09:41,160 RELEVANT, WE MUST BRIDGE THIS 231 00:09:41,160 --> 00:09:43,760 GAP WHEN A NEW APPROACH IS 232 00:09:43,760 --> 00:09:45,080 IDENTIFIED, TO ENSURE THAT ALL 233 00:09:45,080 --> 00:09:50,000 OF OUR ADVANCES, BENEFIT ALL WHO 234 00:09:50,000 --> 00:09:50,600 NEED THEM. 235 00:09:50,600 --> 00:09:52,080 I BELIEVE STRONGLY IF WE WERE 236 00:09:52,080 --> 00:09:53,920 GOING TO END CANCER AS WE KNOW 237 00:09:53,920 --> 00:09:58,320 IT, IT WILL TAKE AN 238 00:09:58,320 --> 00:09:58,960 ALL-OF-SOCIETY APPROACH. 239 00:09:58,960 --> 00:10:00,480 NCI CANNOT DO THIS ALONE. 240 00:10:00,480 --> 00:10:04,240 IN THIS POST, I ALSO TOUCHED 241 00:10:04,240 --> 00:10:06,040 BRIEFLY ON SOMETHING WE'RE 242 00:10:06,040 --> 00:10:08,320 CALLING THE NATIONAL CANCER 243 00:10:08,320 --> 00:10:12,360 PLAN, WHICH IS AIMED AT THIS 244 00:10:12,360 --> 00:10:14,720 EXACT ISSUE. 245 00:10:14,720 --> 00:10:18,400 AS LEADER OF THIS NATIONAL 246 00:10:18,400 --> 00:10:22,120 CANCER PROGRAM, SOMETHING I AM 247 00:10:22,120 --> 00:10:23,280 CHARGE WITH BASED ON THE 248 00:10:23,280 --> 00:10:27,680 NATIONAL CANCER ACT OF 1971, 249 00:10:27,680 --> 00:10:30,080 WE'VE WORKED WITH RESEARCHERS, 250 00:10:30,080 --> 00:10:33,440 BOTH WITHIN AND OUTSIDE OF NCI 251 00:10:33,440 --> 00:10:34,640 TO PRODUCE SOMETHING WE ARE 252 00:10:34,640 --> 00:10:36,240 CALLING THE NATIONAL CANCER 253 00:10:36,240 --> 00:10:36,800 PLAN. 254 00:10:36,800 --> 00:10:40,600 WHICH IS A PLAN FOR US TO ALIGN 255 00:10:40,600 --> 00:10:43,120 BROAD SOCIETAL ENGAGEMENT AND 256 00:10:43,120 --> 00:10:45,800 FOCUS ON CRITICAL NEEDS TO 257 00:10:45,800 --> 00:10:49,000 ENTITLED CANC END CANCER AS WE W 258 00:10:49,000 --> 00:10:49,560 IT. 259 00:10:49,560 --> 00:10:52,240 THE NATIONAL CANCER PLAN 260 00:10:52,240 --> 00:10:54,000 EMPHASIZES THAT EVERYONE HAS A 261 00:10:54,000 --> 00:10:57,880 ROLE IN MAKING THE BROADEST -- 262 00:10:57,880 --> 00:11:00,120 AND ACHIEVING THE BROADEST GOAL 263 00:11:00,120 --> 00:11:02,640 WHICH IS TO HELP PEOPLE WITH 264 00:11:02,640 --> 00:11:05,040 CANCER LIVE FULL AND ACTIVE LIFE 265 00:11:05,040 --> 00:11:07,040 FREE FROM THE EFFECTS OF CANCER 266 00:11:07,040 --> 00:11:10,040 AND THAT MEANS EVERYBODY WITH 267 00:11:10,040 --> 00:11:12,880 CANCER AND EVERY CANCER. 268 00:11:12,880 --> 00:11:15,320 THE PLAN OUTLINES RESENT 269 00:11:15,320 --> 00:11:17,280 PROGRESS AND WHAT IT TAKES TO 270 00:11:17,280 --> 00:11:22,560 SUSTAIN AND ACCELERATE IT AND 271 00:11:22,560 --> 00:11:25,080 WHAT IT WILL TAKE TO ACCELERATE 272 00:11:25,080 --> 00:11:27,360 IT AND EMBRACES THE IDEA THAT 273 00:11:27,360 --> 00:11:29,120 EVERYONE HAS A ROLE TO PLAY OF 274 00:11:29,120 --> 00:11:31,680 ACROSS FEDERAL AGENCIES, AS WELL 275 00:11:31,680 --> 00:11:35,880 AS INDUSTRY, ACADEMIA, ADVOCACY 276 00:11:35,880 --> 00:11:38,720 GROUPS, NON PROFITS, EVEN 277 00:11:38,720 --> 00:11:40,560 CAREGIVERS AND PATIENTS. 278 00:11:40,560 --> 00:11:43,160 OUR INTENT IS THAT WHEN ANY 279 00:11:43,160 --> 00:11:44,720 ORGANIZATION OR PERSON LOOKS AT 280 00:11:44,720 --> 00:11:46,240 THIS PLAN, THEY WILL SEE WHERE 281 00:11:46,240 --> 00:11:49,920 THEY FIT IN AS A CONTRIBUTOR TO 282 00:11:49,920 --> 00:11:50,800 PROGRESS AND THEY WILL ALSO BE 283 00:11:50,800 --> 00:11:53,400 ABLE TO SEE THE FULL PICTURE OF 284 00:11:53,400 --> 00:11:55,080 MANY INTER RELATED ACTIONS 285 00:11:55,080 --> 00:11:58,760 NEEDED TO END CANCER AS WE KNOW 286 00:11:58,760 --> 00:11:59,200 IT. 287 00:11:59,200 --> 00:12:02,320 WE'RE IN A PHASE NOW WHICH WE'RE 288 00:12:02,320 --> 00:12:04,320 GETTING INPUT FROM A WIDE RANGE 289 00:12:04,320 --> 00:12:05,760 OF STAKEHOLDERS ON THIS PLAN 290 00:12:05,760 --> 00:12:08,480 THAT WILL BE FINALIZED AND 291 00:12:08,480 --> 00:12:10,680 COMMUNICATED WIDELY THROUGH THE 292 00:12:10,680 --> 00:12:13,040 PUBLIC. 293 00:12:13,040 --> 00:12:13,720 NEXT SLIDE. 294 00:12:13,720 --> 00:12:21,120 O, NOW SOME UPDANCI'S CENTER FOH 295 00:12:21,120 --> 00:12:25,160 AND THE DIVISION OF CANCER 296 00:12:25,160 --> 00:12:26,560 EPIDEMIOLOGY AND GENETICS 297 00:12:26,560 --> 00:12:28,720 PRODUCE THE RESULTS WE NEED FOR 298 00:12:28,720 --> 00:12:29,520 PROGRESS. 299 00:12:29,520 --> 00:12:31,640 CCR RESEARCHERS HAVE HELPED US 300 00:12:31,640 --> 00:12:35,080 TO BETTER UNDERSTAND, FOR 301 00:12:35,080 --> 00:12:38,280 EXAMPLE, MESA THEME OL A FORM OF 302 00:12:38,280 --> 00:12:39,920 CANCER THAT INVOLVES THE LUNGS 303 00:12:39,920 --> 00:12:42,680 AND LINING OF THE ABDOMINAL 304 00:12:42,680 --> 00:12:44,240 CAVITY, AND IT'S PROVEN VERY 305 00:12:44,240 --> 00:12:45,960 DIFFICULT TO TREAT. 306 00:12:45,960 --> 00:12:48,000 CCR RESEARCHERS HAVE IDENTIFIED 307 00:12:48,000 --> 00:12:51,200 A 48-GENE SIGNATURE IN WHICH 308 00:12:51,200 --> 00:12:53,080 HIGH-EXPRESSION OF CERTAIN GENES 309 00:12:53,080 --> 00:12:57,320 ARE ASSOCIATED WITH WORSE 310 00:12:57,320 --> 00:13:01,280 SURVIVAL IN PLURAL AND PER 311 00:13:01,280 --> 00:13:04,120 TENILLE MESA THEME A OL A AND 312 00:13:04,120 --> 00:13:06,160 ANTI-PD1 THERAPY AND DRUG 313 00:13:06,160 --> 00:13:09,400 COMBINATIONS INVOLVING PEMATRXID 314 00:13:09,400 --> 00:13:11,440 WERE EFFECTIVE FOR TWO OF 315 00:13:11,440 --> 00:13:18,040 SUBSETS OF PATIENTS WITH MESA 316 00:13:18,040 --> 00:13:23,000 FEEL' OWN A N ADDITION A PHASE 317 00:13:23,000 --> 00:13:24,040 CLINICAL TRIAL FROM THE 318 00:13:24,040 --> 00:13:26,080 FREDERICK NATIONAL LABORATORIES 319 00:13:26,080 --> 00:13:31,240 SHOWED LOW-DOSE TEMADOLOMIA AND 320 00:13:31,240 --> 00:13:34,200 TDMI MAY PREVENT BRAIN MATAS 321 00:13:34,200 --> 00:13:35,760 ADVERTISE FOR BREAST CANCER S 322 00:13:35,760 --> 00:13:39,360 83% OF PATIENTS IN THIS STUDY 323 00:13:39,360 --> 00:13:42,680 DEVELOPED NO NEW BRAIN 324 00:13:42,680 --> 00:13:43,960 METASTASIS, A REMARKABLE RESULT 325 00:13:43,960 --> 00:13:45,000 AND WE LOOK FORWARD TO SEEING 326 00:13:45,000 --> 00:13:47,440 THIS VERY IMPORTANT PHASE 1 327 00:13:47,440 --> 00:13:49,680 RESULT MOVING FORWARD. 328 00:13:49,680 --> 00:13:51,840 WE ALL KNOW THAT TRANSGENDER AND 329 00:13:51,840 --> 00:13:56,280 GENDER DIVERSE PEOPLE OFTEN FACE 330 00:13:56,280 --> 00:13:57,640 DISCRIMINATION AND 331 00:13:57,640 --> 00:13:58,880 MARGINALIZATION. 332 00:13:58,880 --> 00:14:00,080 DCEG RESEARCHERS HAVE BEEN 333 00:14:00,080 --> 00:14:02,360 LOOKING INTO THE EFFECTS OF 334 00:14:02,360 --> 00:14:03,320 THIS. 335 00:14:03,320 --> 00:14:07,120 THEY FOUND DATA FROM THE U.K. 336 00:14:07,120 --> 00:14:10,760 THAT TRANSGENDER AND DIVERSE 337 00:14:10,760 --> 00:14:13,320 PEOPLE IN FACT HAVE AN ELEVATED 338 00:14:13,320 --> 00:14:15,400 RISK OF OVER ALL MORTALITY, 339 00:14:15,400 --> 00:14:17,040 COMPARED TO CISGENDER PEOPLE DUE 340 00:14:17,040 --> 00:14:19,080 TO EXTERNAL CAUSES OF DEATH. 341 00:14:19,080 --> 00:14:22,920 SUCH AS SUICIDES, HOMICIDES, AND 342 00:14:22,920 --> 00:14:24,840 ACCIDENTAL POISONING. 343 00:14:24,840 --> 00:14:26,960 AS WELL AS ENDOCRINE DISORDERS 344 00:14:26,960 --> 00:14:27,880 AND OTHER CAUSES. 345 00:14:27,880 --> 00:14:31,240 CONCERNING CANCER MORTALITY, 346 00:14:31,240 --> 00:14:31,800 TRANCE FEMININE INDIVIDUALS 347 00:14:31,800 --> 00:14:33,640 WHICH ARE PEOPLE ASSIGNED MALE 348 00:14:33,640 --> 00:14:36,320 AT BIRTH, HAVE DECREASED RISK OF 349 00:14:36,320 --> 00:14:40,120 DEATH FROM CANCER, COMPARED TO 350 00:14:40,120 --> 00:14:43,600 CISGENDER WOMEN, BUT THE SAME AS 351 00:14:43,600 --> 00:14:47,840 CISGENDER MEN. 352 00:14:47,840 --> 00:14:48,400 TRANS-MASCULINE INDIVIDUALS, 353 00:14:48,400 --> 00:14:50,480 PEOPLE ASSIGNED FEMALE AT BIRTH, 354 00:14:50,480 --> 00:14:52,160 EXPERIENCED OF COMPARABLE RISK 355 00:14:52,160 --> 00:14:56,520 OF DEATH FROM CANCER TO THAT OF 356 00:14:56,520 --> 00:14:57,920 CISGENDER INDIVIDUALS. 357 00:14:57,920 --> 00:14:59,360 CANCER CARE MEANS THAT WE 358 00:14:59,360 --> 00:15:02,040 SUPPORT THE NEEDS OF THE WHOLE 359 00:15:02,040 --> 00:15:02,400 PERSON. 360 00:15:02,400 --> 00:15:05,240 AND THERE'S CLEARLY A NEED TO 361 00:15:05,240 --> 00:15:07,800 DEVELOP INTERVENTIONS SUCH AS 362 00:15:07,800 --> 00:15:09,720 MENTAL HEALTH AND SOCIAL SUPPORT 363 00:15:09,720 --> 00:15:13,720 TO PREVENT SUICIDE AND VIOLENCE 364 00:15:13,720 --> 00:15:16,680 THAT AMONG THESE POPULATIONS. 365 00:15:16,680 --> 00:15:19,040 WE'RE CELEBRATING THE 50th 366 00:15:19,040 --> 00:15:21,200 ANNIVERSARY OF THE SURVEILLANCE 367 00:15:21,200 --> 00:15:26,400 EPIDEMIOLOGY AND END RESULTS 368 00:15:26,400 --> 00:15:27,800 PROGRAM OR CAR. 369 00:15:27,800 --> 00:15:29,840 AS IT PROVIDES INVALUABLE DATA 370 00:15:29,840 --> 00:15:31,240 FROM REGISTRIES THAT COVER 371 00:15:31,240 --> 00:15:34,640 ALMOST HALF OF THE U.S. 372 00:15:34,640 --> 00:15:36,520 POPULATION. 373 00:15:36,520 --> 00:15:38,640 DCEG SHARED A GREAT POST ON ITS 374 00:15:38,640 --> 00:15:40,400 SITE THAT TALKS ABOUT THE 375 00:15:40,400 --> 00:15:41,600 IMPORTANT ROLE THEY PLAY IN MUCH 376 00:15:41,600 --> 00:15:42,920 OF THE RESEARCH. 377 00:15:42,920 --> 00:15:43,960 THROUGHOUT THE REST OF THE YEAR, 378 00:15:43,960 --> 00:15:46,320 YOU WILL SEE A SERIES OF 379 00:15:46,320 --> 00:15:50,040 INFORMATION ON SARS-CoV- CONTRIO 380 00:15:50,040 --> 00:15:51,360 CANCER RESEARCH AND 381 00:15:51,360 --> 00:15:53,640 PUBLIC-HEALTH AS WELL, ON-LINE, 382 00:15:53,640 --> 00:15:56,160 ON SOCIAL MEDIA AND VARIOUS 383 00:15:56,160 --> 00:15:57,360 EVENTS. 384 00:15:57,360 --> 00:16:00,720 FINALLY, I'LL ALSO NOTE THAT 385 00:16:00,720 --> 00:16:02,760 DCEG AND EXPERTS ARE 386 00:16:02,760 --> 00:16:03,840 PARTICIPATING IN THE 387 00:16:03,840 --> 00:16:06,240 INTERNATIONAL PAPILLOMA VIRUS 388 00:16:06,240 --> 00:16:07,880 SOCIETY AN ACTUAL MEETING, 389 00:16:07,880 --> 00:16:09,600 TAKING PLACE IN WASHING NOT TON 390 00:16:09,600 --> 00:16:11,120 D.C. NEXT MONTH. 391 00:16:11,120 --> 00:16:12,760 DOUG LOWY, WHO NEEDS NO 392 00:16:12,760 --> 00:16:14,920 INTRODUCTION, WHEN IT COMES TO 393 00:16:14,920 --> 00:16:16,720 HPV EXPERTS, IS GIVING THE 394 00:16:16,720 --> 00:16:18,520 KEYNOTE ON THE LAST DAY. 395 00:16:18,520 --> 00:16:22,280 NEXT SLIDE, PLEASE. 396 00:16:22,280 --> 00:16:23,800 ANOTHER HIGHLIGHT I'LL SHARE 397 00:16:23,800 --> 00:16:27,600 WITH YOU IS ABOUT THE CANCER 398 00:16:27,600 --> 00:16:29,840 CARE -- CHILDHOOD CANCER DATA 399 00:16:29,840 --> 00:16:30,800 INITIATIVE. 400 00:16:30,800 --> 00:16:33,240 GETTING DATA WE NEEDS TO IMPROVE 401 00:16:33,240 --> 00:16:36,480 OUR UNDERSTANDING OF CANCER. 402 00:16:36,480 --> 00:16:38,400 ESPECIALLY CHILDHOOD CANCER, IS 403 00:16:38,400 --> 00:16:41,560 VERY CHALLENGING AND COSTLY. 404 00:16:41,560 --> 00:16:44,680 THE GOOD NEWS IS, WE'RE MAKING 405 00:16:44,680 --> 00:16:46,800 GREAT HEAD WAY TO GET MUCH 406 00:16:46,800 --> 00:16:48,720 NEEDED CHILDHOOD CANCER DATA 407 00:16:48,720 --> 00:16:50,960 INTO THE HANDS OF SCIENTISTS, 408 00:16:50,960 --> 00:16:54,280 THROUGH CCDI. 409 00:16:54,280 --> 00:16:58,160 THIS FOCUSED PROGRAM HAS MADE 410 00:16:58,160 --> 00:16:59,360 TREMENDOUS PROGRESS TO 411 00:16:59,360 --> 00:17:01,360 ACCUMULATE DATA THAT HAS 412 00:17:01,360 --> 00:17:02,800 HISTORICALLY BEEN VERY 413 00:17:02,800 --> 00:17:05,040 CHALLENGING FOR RESEARCHERS TO 414 00:17:05,040 --> 00:17:05,400 ACCESS. 415 00:17:05,400 --> 00:17:08,040 THIS YEAR, GREG REEMAN HAS TAKEN 416 00:17:08,040 --> 00:17:10,560 CHARGE OF CCDI BRINGING HIS VAST 417 00:17:10,560 --> 00:17:13,640 EXPERIENCE FROM HUSBA HIS TIME G 418 00:17:13,640 --> 00:17:15,480 THE CHILDREN'S ONCOLOGY GROUP 419 00:17:15,480 --> 00:17:17,280 AND WORKING AT FDA. 420 00:17:17,280 --> 00:17:20,400 THE TEAM CONTINUES TO ADD TO 421 00:17:20,400 --> 00:17:22,920 CCDI'S TECHNOLOGICAL 422 00:17:22,920 --> 00:17:24,080 CAPABILITIES WITH NUMEROUS 423 00:17:24,080 --> 00:17:25,720 UPDATES OVER THE LAST SEVERAL 424 00:17:25,720 --> 00:17:29,960 MONTHS THAT MAKE IT EASIER AND 425 00:17:29,960 --> 00:17:30,840 BETTER. 426 00:17:30,840 --> 00:17:33,360 EASIER AND MORE EFFECTIVE FOR 427 00:17:33,360 --> 00:17:35,560 RESEARCHERS TO USE CCDI DATA. 428 00:17:35,560 --> 00:17:38,600 AND FINALLY ON MARCH 24th, 429 00:17:38,600 --> 00:17:42,840 CCDI WILL HOST AN ANNUAL 430 00:17:42,840 --> 00:17:44,280 SYMPOSIUM THAT WILL GATHER 431 00:17:44,280 --> 00:17:45,920 EXPERTS FROM ACROSS THE COUNTRY 432 00:17:45,920 --> 00:17:48,000 TO DISCUSS THE OVER ALL PROJECT 433 00:17:48,000 --> 00:17:52,480 OF THE INITIATIVE, THE NEW 434 00:17:52,480 --> 00:17:56,520 RESOURCES AVAILABLE TO THE BROAD 435 00:17:56,520 --> 00:17:57,120 SCIENTIFIC COMMUNITY AND 436 00:17:57,120 --> 00:17:58,080 OPPORTUNITIES FOR THE FUTURE. 437 00:17:58,080 --> 00:17:59,840 IF YOU CAN, I STRONGLY ENCOURAGE 438 00:17:59,840 --> 00:18:02,400 YOU TO ATTEND, WHICH YOU CAN DO 439 00:18:02,400 --> 00:18:04,120 IN-PERSON OR VIRTUALLY. 440 00:18:04,120 --> 00:18:07,640 EVEN IF YOU ARE NOT A 441 00:18:07,640 --> 00:18:08,720 RESEARCHER, PARTICULARLY 442 00:18:08,720 --> 00:18:12,160 INTERESTED IN CHILDHOOD CANCER, 443 00:18:12,160 --> 00:18:14,240 ATTENDING THIS SYMPOSIUM WILL 444 00:18:14,240 --> 00:18:17,120 ALLOW YOU TO SEE WHAT IS 445 00:18:17,120 --> 00:18:23,000 POSSIBLE I IF WE NOW SCALE EFFOS 446 00:18:23,000 --> 00:18:26,080 SUCH AS CCDI ACROSS OUR ENTIRE 447 00:18:26,080 --> 00:18:26,880 CANCER ECOSYSTEM. 448 00:18:26,880 --> 00:18:29,200 THIS IS ONE OF THE MAIN GOALS OF 449 00:18:29,200 --> 00:18:34,440 NCI OVER ALL. 450 00:18:34,440 --> 00:18:38,920 SO, SOME FINAL THOUGHTS, I'LL 451 00:18:38,920 --> 00:18:40,360 WRAP-UP HERE. 452 00:18:40,360 --> 00:18:43,760 THERE'S A LOT HAPPENING FROM 453 00:18:43,760 --> 00:18:45,360 STEP-BY-STEP SCIENCE WE WON'T 454 00:18:45,360 --> 00:18:45,920 MAKE PROGRESS WITHOUT. 455 00:18:45,920 --> 00:18:47,840 TO HIGH-LEVEL PLANNING TO BEST 456 00:18:47,840 --> 00:18:51,400 LEAD AND ALIGN THE CANCER 457 00:18:51,400 --> 00:18:53,960 RESEARCH ENTERPRISE, TRULY, ALL 458 00:18:53,960 --> 00:18:56,280 OF SOCIETY, AS WE ACHIEVE 459 00:18:56,280 --> 00:18:57,680 PROGRESS EVERYONE IS COUNTING 460 00:18:57,680 --> 00:18:58,280 ON. 461 00:18:58,280 --> 00:18:59,600 WE'RE STILL VERY FAR FROM WHERE 462 00:18:59,600 --> 00:19:01,320 WE NEED TO BE FOR THE MILLIONS 463 00:19:01,320 --> 00:19:03,200 OF PEOPLE OUT THERE STILL FACING 464 00:19:03,200 --> 00:19:05,600 THIS AWFUL DISEASE AND THE MANY 465 00:19:05,600 --> 00:19:07,960 MORE WE HOPE TO PREVENT FROM 466 00:19:07,960 --> 00:19:09,960 EVER HAVING TO DO SO. 467 00:19:09,960 --> 00:19:13,280 BUT I'M REALLY EXCITED ABOUT THE 468 00:19:13,280 --> 00:19:15,840 STEPS RETAKING NOW AND RECENT 469 00:19:15,840 --> 00:19:16,600 ACCOMPLISHMENTS THAT ENSURE 470 00:19:16,600 --> 00:19:18,440 WE'RE ON THE RIGHT PATH. 471 00:19:18,440 --> 00:19:20,120 SO, LET ME END THERE AND GET TO 472 00:19:20,120 --> 00:19:22,160 THE BEST PART OF MY TIME WITH 473 00:19:22,160 --> 00:19:25,480 YOU TODAY. 474 00:19:25,480 --> 00:19:28,920 THAT IS BEING ABLE TO TAKE YOUR 475 00:19:28,920 --> 00:19:29,200 QUESTIONS. 476 00:19:29,200 --> 00:19:33,320 >>THANK YOU, MUCH Dr. 477 00:19:33,320 --> 00:19:35,120 BERTAGNOLLI AND WE OPEN IT UP TO 478 00:19:35,120 --> 00:19:36,440 QUESTIONS NOW. 479 00:19:36,440 --> 00:19:40,920 I BELIEVE Dr. CHUCK RIVARDI 480 00:19:40,920 --> 00:19:44,920 HAS HIS HAND UP. 481 00:19:44,920 --> 00:19:47,600 >>THANK YOU SO MUCH, Dr. 482 00:19:47,600 --> 00:19:49,680 BERTAGNOLLI, FOR YOUR TREMENDOUS 483 00:19:49,680 --> 00:19:50,320 LEADERSHIP. 484 00:19:50,320 --> 00:19:52,120 I THINK WE'RE ALL VERY EXCITED 485 00:19:52,120 --> 00:19:54,800 ABOUT WHAT THE FUTURE HOLDS FOR 486 00:19:54,800 --> 00:19:56,640 THE NCI UNDER YOUR RELATIONSHIP. 487 00:19:56,640 --> 00:19:57,840 SO, THANK YOU. 488 00:19:57,840 --> 00:20:01,040 I JUST HAD SEVERAL QUICK 489 00:20:01,040 --> 00:20:03,960 QUESTIONS. 490 00:20:03,960 --> 00:20:07,440 THE FIRST BEING PRESIDENT JOE 491 00:20:07,440 --> 00:20:10,200 BIDEN'S ROLLOUT OF THE ARPA-H 492 00:20:10,200 --> 00:20:14,040 PROGRAM AND HOW IT DOVE TAILS 493 00:20:14,040 --> 00:20:16,560 WITH THE NIH OVER ALL MISSION? 494 00:20:16,560 --> 00:20:18,760 WHERE DID IT BEGIN AND END AND 495 00:20:18,760 --> 00:20:21,200 SO FOURTH? 496 00:20:21,200 --> 00:20:21,800 >>Dr. Bertagnolli: GREAT 497 00:20:21,800 --> 00:20:22,760 QUESTION. 498 00:20:22,760 --> 00:20:27,840 SO, FIRST OF ALL, RENEE WAGERSON 499 00:20:27,840 --> 00:20:29,760 AND THE NEW ARPA-H DIRECTOR AND 500 00:20:29,760 --> 00:20:31,320 I ARE IN FREQUENT 501 00:20:31,320 --> 00:20:32,040 COMMUNICATIONS. 502 00:20:32,040 --> 00:20:33,840 WE TALK EVERY OTHER WEEK. 503 00:20:33,840 --> 00:20:35,080 WHY ARE WE DOING THAT? 504 00:20:35,080 --> 00:20:37,800 IT'S BECAUSE WE'RE WORKING 505 00:20:37,800 --> 00:20:41,840 TOGETHER TO DECIDE HOW ARPA-H 506 00:20:41,840 --> 00:20:43,880 AND NCI CAN HAVE THE MOST 507 00:20:43,880 --> 00:20:45,320 POWERFUL COLLABORATION. 508 00:20:45,320 --> 00:20:49,560 THE IDEA IS THIS -- IN GENERAL, 509 00:20:49,560 --> 00:20:53,360 NCI HAS TO TAKE THE VERY LONG 510 00:20:53,360 --> 00:20:53,840 VIEW. 511 00:20:53,840 --> 00:20:57,600 WE ARE RESPONSIBLE FOR 512 00:20:57,600 --> 00:21:00,080 EVERYTHING FROM BASIC, 513 00:21:00,080 --> 00:21:02,240 FUNDAMENTAL SCIENCE, BASIC 514 00:21:02,240 --> 00:21:05,640 DISCOVERY, ALL THE WAY TO CANCER 515 00:21:05,640 --> 00:21:08,720 CARE DELIVERY RESEARCH THAT 516 00:21:08,720 --> 00:21:11,080 MAKES SURE THAT A RESULT, TAKEN 517 00:21:11,080 --> 00:21:13,120 ALL THE WAY FROM THE LAB THROUGH 518 00:21:13,120 --> 00:21:15,360 CLINICAL TRIALS, GETS TO THE 519 00:21:15,360 --> 00:21:18,720 PATIENTS WHO REALLY NEED IT. 520 00:21:18,720 --> 00:21:19,480 THE HAVE LONG AND VERY 521 00:21:19,480 --> 00:21:20,040 BROADVIEW. 522 00:21:20,040 --> 00:21:28,760 VERY LONG BROAD.IT TAKES YEARS D 523 00:21:28,760 --> 00:21:31,520 THAT'S THE VIEW WE HAVE TO HAVE. 524 00:21:31,520 --> 00:21:32,960 ARPA-H'S FOCUS IS DIFFERENT. 525 00:21:32,960 --> 00:21:38,720 IT IS DESIGNED TO IDENTIFY 526 00:21:38,720 --> 00:21:41,480 PARTICULAR KEY QUESTIONS -- KEY 527 00:21:41,480 --> 00:21:44,680 PROBLEMS, THAT ARE AMENABLE TO 528 00:21:44,680 --> 00:21:48,880 HIGH-RISK, HIGH REWARD, RESEARCH 529 00:21:48,880 --> 00:21:51,920 FOCUS. 530 00:21:51,920 --> 00:21:58,720 THEY PICK THESE AND PROVIDE A 531 00:21:58,720 --> 00:22:02,160 REALLY INTENSE, ACROSS THE 532 00:22:02,160 --> 00:22:04,040 BOARD, STRATEGY TO SOLVING THEM. 533 00:22:04,040 --> 00:22:05,400 I'LL GIVE YOU AN EXAMPLE. 534 00:22:05,400 --> 00:22:07,680 THIS IS ONE THAT WE'VE DEVELOPED 535 00:22:07,680 --> 00:22:09,360 TOGETHER WITH Dr. WAGERSON AND 536 00:22:09,360 --> 00:22:11,400 I KNOW WE WILL BE COLLABORATING 537 00:22:11,400 --> 00:22:13,240 WITH ARPA-H ON. 538 00:22:13,240 --> 00:22:15,400 ONE OF THE THINGS WE NEED TO DO 539 00:22:15,400 --> 00:22:19,640 TODAY IS TO BE ABLE TO INTEGRATE 540 00:22:19,640 --> 00:22:22,600 PATHOLOGY, CLINICAL PATHOLOGY, 541 00:22:22,600 --> 00:22:27,120 THE IMAGES THAT COME OFF OF H 542 00:22:27,120 --> 00:22:31,160 AND E SLIDES WITH ALL OF THE 543 00:22:31,160 --> 00:22:33,160 COMPLEX WAYS THAT WE INTERROGATE 544 00:22:33,160 --> 00:22:35,560 A TIME OR. 545 00:22:35,560 --> 00:22:37,600 PROTEOMICS, GENOMICS, SINGLE 546 00:22:37,600 --> 00:22:43,040 CELL, SINGLE CELL TRANCE TRANSCT 547 00:22:43,040 --> 00:22:43,680 OMICS, ET CETERA. 548 00:22:43,680 --> 00:22:45,040 WE HAVE TO PROVIDE THAT DATA IN 549 00:22:45,040 --> 00:22:48,520 A FORMAT THAT ALLOWS 550 00:22:48,520 --> 00:22:51,800 PATHOLOGISTS TO ACHIEVED BETTER 551 00:22:51,800 --> 00:22:54,200 DIAGNOSIS AND CLINICIAN TO 552 00:22:54,200 --> 00:22:57,040 ACHIEVE BETTER TARGETED 553 00:22:57,040 --> 00:22:57,880 TREATMENTS. 554 00:22:57,880 --> 00:23:02,760 WE DON'T HAVE THE SYSTEMS RIGHT 555 00:23:02,760 --> 00:23:04,920 NOW THE TECHNOLOGY, THE 556 00:23:04,920 --> 00:23:08,520 SOFTWARE, TO PULL ALL OF THOSE 557 00:23:08,520 --> 00:23:16,800 DISPARATE DATA STREAMS TOGETHER. 558 00:23:16,800 --> 00:23:18,240 THAT'S A PERFECT ARPA-H PROJECT. 559 00:23:18,240 --> 00:23:20,200 WE ARE PLANNING FOR THIS 560 00:23:20,200 --> 00:23:23,280 INTEGRATED PATHOLOGY AND IMAGING 561 00:23:23,280 --> 00:23:25,600 APPROACH TO BE DEVELOPED AND IT 562 00:23:25,600 --> 00:23:28,680 WILL PROBABLY INVOLVE MULTIPLE 563 00:23:28,680 --> 00:23:32,480 PARTNERS, MULTIPLE DIFFERENT 564 00:23:32,480 --> 00:23:33,720 EFFORTS AND NCI RESEARCHERS WHO 565 00:23:33,720 --> 00:23:35,960 NEED TO TAKE THIS NEW PRODUCT 566 00:23:35,960 --> 00:23:38,760 AND USE IT FOR OUR OWN RESEARCH 567 00:23:38,760 --> 00:23:40,560 AND TRANSLATION TO CLINICAL 568 00:23:40,560 --> 00:23:47,400 CARE, WILL BE AT THE ELBOW OF 569 00:23:47,400 --> 00:23:49,440 THOSE IN ARPA-H H DEVELOPING 570 00:23:49,440 --> 00:23:50,800 THESE SO IT'S A NEW WAY OF 571 00:23:50,800 --> 00:23:51,800 THINKING OF THINGS, I GUESS IN 572 00:23:51,800 --> 00:23:55,640 THE OLD DAYS, WE MIGHT DEVELOP A 573 00:23:55,640 --> 00:24:00,280 NEW FOCUS FOR SOMETHING LIKE 574 00:24:00,280 --> 00:24:01,880 THIS WITHIN NCI SOMEWHERE, BUT 575 00:24:01,880 --> 00:24:03,640 BOY IT'S A TREMENDOUS BENEFIT TO 576 00:24:03,640 --> 00:24:05,800 ALL OF US TO HAVE THIS NEW 577 00:24:05,800 --> 00:24:08,080 ENTITY, THIS NEW FUNDING, AND 578 00:24:08,080 --> 00:24:10,680 THIS NEW ENTHUSIASM TO DO WORK 579 00:24:10,680 --> 00:24:14,480 LIKE THIS IF WE CAN BE CLOSE 580 00:24:14,480 --> 00:24:14,760 PARTNERS. 581 00:24:14,760 --> 00:24:16,880 >>Dr. BERTAGNOLLI, JUST TO 582 00:24:16,880 --> 00:24:21,800 FOLLOW-UP, SO WITHIN THE OS 583 00:24:21,800 --> 00:24:25,440 PISISTHERE HIGH REWARD AND HIGHK 584 00:24:25,440 --> 00:24:30,120 TYPE OF RESEARCH VERSUS THE MORE 585 00:24:30,120 --> 00:24:32,480 TRADITIONAL HYPOTHESIS RESEARCH 586 00:24:32,480 --> 00:24:34,640 AND WHAT ARE THE UNIQUE ASPECTS 587 00:24:34,640 --> 00:24:41,160 OF THE INTRAMURAL PROGRAM IS 588 00:24:41,160 --> 00:24:43,560 THAT IN THAT A LOT OF THE 589 00:24:43,560 --> 00:24:44,720 PROJECTS ARE AMBITION AND OUT OF 590 00:24:44,720 --> 00:24:46,360 THE BOX IN THINKING. 591 00:24:46,360 --> 00:24:49,760 SO AS REVIEWERS, SHOULD WE 592 00:24:49,760 --> 00:24:51,960 CONTINUE TO REWARD CUTTING THE 593 00:24:51,960 --> 00:24:54,200 HIGH-RISK HIGH-REWARD TYPE OF 594 00:24:54,200 --> 00:24:56,920 ENDEAVOR WITHIN THE INTRAMURAL 595 00:24:56,920 --> 00:24:58,080 PROGRAM? 596 00:24:58,080 --> 00:24:59,400 THANK YOU. 597 00:24:59,400 --> 00:25:00,040 >>Dr. Bertagnolli: ABSOLUTELY. 598 00:25:00,040 --> 00:25:02,000 ABSOLUTELY. 599 00:25:02,000 --> 00:25:03,160 LOOK, WE NEED BALANCE. 600 00:25:03,160 --> 00:25:05,920 WE NEED BALANCE IN WHAT WE DO. 601 00:25:05,920 --> 00:25:09,240 WE CAN'T IGNORE THE BENEFITS 602 00:25:09,240 --> 00:25:11,160 THAT CAN COME WHEN YOU GET THE 603 00:25:11,160 --> 00:25:13,440 BRASS RING IN A HIGH-RISK HIGH 604 00:25:13,440 --> 00:25:15,120 REWARD ENDEAVOR AND I THINK YOU 605 00:25:15,120 --> 00:25:18,080 ARE ALL VERY WISE IN ENCOURAGING 606 00:25:18,080 --> 00:25:19,640 THAT, ENCOURAGING THAT THAT KIND 607 00:25:19,640 --> 00:25:24,040 OF RESEARCH HAS A HOME AT NCI. 608 00:25:24,040 --> 00:25:27,240 ALSO, WE CAN'T FORGET, THAT 609 00:25:27,240 --> 00:25:30,240 STEADY INCREMENTAL PROGRESS HAS 610 00:25:30,240 --> 00:25:32,320 ACHIEVED TREMENDOUS BENEFITS IF 611 00:25:32,320 --> 00:25:33,080 OUR PATIENTS. 612 00:25:33,080 --> 00:25:35,080 YOU KNOW, THAT IS NOT TO BE 613 00:25:35,080 --> 00:25:38,080 UNDER APPRECIATED OR UNDER 614 00:25:38,080 --> 00:25:39,160 RESOURCED. 615 00:25:39,160 --> 00:25:41,160 SO, IT'S ALWAYS ABOUT THE 616 00:25:41,160 --> 00:25:43,520 BALANCE AND THIS IS WHY WE'RE 617 00:25:43,520 --> 00:25:45,520 GRATEFUL FOR YOUR ADVICE AND 618 00:25:45,520 --> 00:25:46,960 YOUR INPUT BECAUSE YOU ARE 619 00:25:46,960 --> 00:25:51,320 CRITICAL TO HELPING US ACHIEVE 620 00:25:51,320 --> 00:25:56,800 THAT BALANCE. 621 00:25:56,800 --> 00:25:58,360 >>ANYBODY ELSE ON THE BOARD 622 00:25:58,360 --> 00:26:03,760 WITH A QUESTION? 623 00:26:03,760 --> 00:26:05,800 I CAN JUMP IN. 624 00:26:05,800 --> 00:26:07,800 I WAS VERY INTRIGUED BY THE 625 00:26:07,800 --> 00:26:09,880 NATIONAL CANCER PLAN THAT YOU 626 00:26:09,880 --> 00:26:12,080 ARE CURRENTLY FORMULATEING AND 627 00:26:12,080 --> 00:26:15,680 WHAT I'M CURIOUS TO HEAR YOUR 628 00:26:15,680 --> 00:26:16,920 THOUGHTS ABOUT IS IN TERMS OF 629 00:26:16,920 --> 00:26:18,560 THE GOAL OF LINING BROAD 630 00:26:18,560 --> 00:26:22,280 SOCIETAL ENGAGEMENT, WHERE IS 631 00:26:22,280 --> 00:26:26,880 THAT INTO EVINEED GREATEST? 632 00:26:26,880 --> 00:26:28,320 HOW ARE YOU PRIORITIZING SO MANY 633 00:26:28,320 --> 00:26:31,680 THINGS THAT FALL UNDER THAT 634 00:26:31,680 --> 00:26:32,000 PARTICULAR -- 635 00:26:32,000 --> 00:26:33,120 >>SO WHAT YOU ARE GOING TO SEE 636 00:26:33,120 --> 00:26:35,440 IN THE NATIONAL CANCER PLAN ARE 637 00:26:35,440 --> 00:26:37,760 EIGHT MAJOR GOALS. 638 00:26:37,760 --> 00:26:39,120 AND NONE OF THESE GOALS ARE 639 00:26:39,120 --> 00:26:41,920 GOING TO BE A SURPRISE TO YOU. 640 00:26:41,920 --> 00:26:47,200 YOU KNOW, THEY ARE ARE THINGS 641 00:26:47,200 --> 00:26:48,240 LIKE -- THEY ARE ALONG THE 642 00:26:48,240 --> 00:26:52,040 THEMES OF CA CANCER PREVENTION, 643 00:26:52,040 --> 00:26:57,200 EARLY DETECTION, ELIMINATING 644 00:26:57,200 --> 00:26:59,000 DISPARITIES, MAINTAINING AND 645 00:26:59,000 --> 00:27:02,760 GROWING AND NURTURING OUR 646 00:27:02,760 --> 00:27:04,240 WORKFORCE FROM SCIENCE ALL THE 647 00:27:04,240 --> 00:27:11,160 WAY THROUGH CARE DELIVERY. 648 00:27:11,160 --> 00:27:13,120 ENSURING DELIVERY OF BEST CARE, 649 00:27:13,120 --> 00:27:13,800 ET CETERA. 650 00:27:13,800 --> 00:27:14,640 YOU ARE GOING TO RECEIVE THE 651 00:27:14,640 --> 00:27:16,640 THINGS YOU KNOW ARE CRITICAL TO 652 00:27:16,640 --> 00:27:19,640 SUCCESS IN ELIMINATING SUFFERING 653 00:27:19,640 --> 00:27:20,840 FOR CANCER. 654 00:27:20,840 --> 00:27:23,920 YOU ARE ALSO GOING TO SEE, I 655 00:27:23,920 --> 00:27:29,920 BELIEVE, THAT EACH OF THESE 656 00:27:29,920 --> 00:27:32,560 OBJECTIVES REQUIRE FAR BEYOND 657 00:27:32,560 --> 00:27:34,160 WHAT NCI ALONE CAN DO. 658 00:27:34,160 --> 00:27:38,440 SO, PART OF THE PLAN IS UNDER 659 00:27:38,440 --> 00:27:41,000 EACH OF THE EAST MAJOR AREAS, 660 00:27:41,000 --> 00:27:43,160 EIGHT MAJOR GOALS WE NEED TO BE 661 00:27:43,160 --> 00:27:44,600 ACHIEVED, YOU WILL SEE A 662 00:27:44,600 --> 00:27:46,760 DESCRIPTION TARGETED 663 00:27:46,760 --> 00:27:48,680 DESCRIPTION, OF WHERE NCI IS 664 00:27:48,680 --> 00:27:51,680 MAKING A MAJOR CONTRIBUTION. 665 00:27:51,680 --> 00:27:54,000 AT THE END, YOU WILL SEE OF A 666 00:27:54,000 --> 00:27:56,720 CALL FOR THE REST OF SOCIETY TO 667 00:27:56,720 --> 00:27:57,200 PARTICIPATE. 668 00:27:57,200 --> 00:28:00,040 SO A QUICK EXAMPLE, PREVENT 669 00:28:00,040 --> 00:28:01,600 CANCER. 670 00:28:01,600 --> 00:28:02,400 OKAY. 671 00:28:02,400 --> 00:28:03,680 OBVIOUSLY YOU KNOW, PROBABLY OUR 672 00:28:03,680 --> 00:28:07,240 MOST IMPORTANT GOAL IN REALLY 673 00:28:07,240 --> 00:28:10,720 HAVING AN IMPACT. 674 00:28:10,720 --> 00:28:13,120 SO, AT NCI, WE CAN DO MORE 675 00:28:13,120 --> 00:28:15,320 FUNDAMENTAL RESEARCH TO 676 00:28:15,320 --> 00:28:18,640 UNDERSTAND EXACTLY WHAT CAUSES 677 00:28:18,640 --> 00:28:20,080 CANCERS, YOU KNOW, SO WE CAN 678 00:28:20,080 --> 00:28:21,680 UNDERSTAND HOW TO INTERVENE AT 679 00:28:21,680 --> 00:28:25,600 THE EARLIEST POINT AND WE CAN 680 00:28:25,600 --> 00:28:27,640 THEN DEPLOY STRATEGIES THAT 681 00:28:27,640 --> 00:28:31,080 LEADS TO EFFECTIVE CANCER 682 00:28:31,080 --> 00:28:33,640 PREVENTION, BUT WHAT WE CAN'T DO 683 00:28:33,640 --> 00:28:37,400 AND WE CAN STUDY THE THINGS THAT 684 00:28:37,400 --> 00:28:39,560 INHIBIT THE PROCESS OF CANCER 685 00:28:39,560 --> 00:28:41,160 BEING PREVENTED. 686 00:28:41,160 --> 00:28:43,640 LIKE, WHAT IS PREVENTING PEOPLE 687 00:28:43,640 --> 00:28:45,840 FROM SMOKING CESSATION? 688 00:28:45,840 --> 00:28:49,160 WHAT ARE THE APPROPRIATE WAYS TO 689 00:28:49,160 --> 00:28:51,520 MAKE SURE THAT UNDER REPRESENTED 690 00:28:51,520 --> 00:28:52,840 POPULATIONS OR POPULATIONS THAT 691 00:28:52,840 --> 00:28:55,920 HAVE HEALTH DISPARITY REALLY 692 00:28:55,920 --> 00:28:57,600 ACHIEVE THE EDUCATION AND 693 00:28:57,600 --> 00:29:01,040 SUPPORT THAT THEY NEED TO 694 00:29:01,040 --> 00:29:02,320 DEVELOP LIFESTYLE FACTORS THAT 695 00:29:02,320 --> 00:29:04,440 WOULD REDUCE CANCER. 696 00:29:04,440 --> 00:29:07,520 AGAIN, PREVENT CANCER HAS WITHIN 697 00:29:07,520 --> 00:29:10,920 IT, GOALS THAT GO FROM BASIC 698 00:29:10,920 --> 00:29:12,480 FUNDAMENTAL SCIENCE ALL THE WAY 699 00:29:12,480 --> 00:29:13,760 THROUGH CARE DELIVERY SO EACH OF 700 00:29:13,760 --> 00:29:15,080 THESE GOALS IS VERY BROAD. 701 00:29:15,080 --> 00:29:19,200 AND AT THE END OF THE DAY, NCI 702 00:29:19,200 --> 00:29:21,000 RESEARCH WON'T DO IT ALONE. 703 00:29:21,000 --> 00:29:22,920 THERE'S A LOT OF THINGS THAT 704 00:29:22,920 --> 00:29:24,960 WOULD HAVE TREMENDOUS IMPACT ON 705 00:29:24,960 --> 00:29:26,160 CANCER PREVENTION. 706 00:29:26,160 --> 00:29:29,360 NEW TOBACCO REGULATION THAT FDA 707 00:29:29,360 --> 00:29:30,880 IS PULLING FORWARD WOULD BE A 708 00:29:30,880 --> 00:29:32,440 TREMENDOUS HELP FOR INSTANCE, SO 709 00:29:32,440 --> 00:29:34,320 FDA WOULD HAVE A MAJOR ROLE TO 710 00:29:34,320 --> 00:29:38,320 PLAY THAT LEGISLATION GOES 711 00:29:38,320 --> 00:29:39,640 THROUGH AND NEW -- AND THEN 712 00:29:39,640 --> 00:29:41,320 RIGHT DOWN TO THE INDIVIDUAL 713 00:29:41,320 --> 00:29:42,320 PATIENT LEVEL. 714 00:29:42,320 --> 00:29:45,480 YOU KNOW, INDIVIDUAL PEOPLE 715 00:29:45,480 --> 00:29:48,800 DOING THEIR PART TO STAY OUT OF 716 00:29:48,800 --> 00:29:51,320 THE SUN, STOP SMOKING, VERY 717 00:29:51,320 --> 00:29:53,080 SIMPLE THINGS SO I THINK THAT 718 00:29:53,080 --> 00:29:54,640 THE POINT WE'RE TRYING TO MAKE 719 00:29:54,640 --> 00:29:56,920 IS NCI CAN DO A TREMENDOUS 720 00:29:56,920 --> 00:29:58,560 AMOUNT BUT IF WE'RE REALLY GOING 721 00:29:58,560 --> 00:30:02,160 TO CO CONQUER THIS DISEASE WE ND 722 00:30:02,160 --> 00:30:03,320 EVERYBODY TO PARTICIPATE. 723 00:30:03,320 --> 00:30:04,160 THAT'S A LITTLE BIT DIFFERENT 724 00:30:04,160 --> 00:30:07,440 THAN WHAT YOU USUALLY SEE WHEN 725 00:30:07,440 --> 00:30:12,880 WHEN WE PUT OUT A CALL FOR 726 00:30:12,880 --> 00:30:15,320 ACTION IN CANCER. 727 00:30:15,320 --> 00:30:16,360 >>THANK YOU. 728 00:30:16,360 --> 00:30:17,640 WE'RE JUST ABOUT OUT OF TIME. 729 00:30:17,640 --> 00:30:18,960 ARE THERE ANY LAST QUESTIONS 730 00:30:18,960 --> 00:30:23,000 FROM THE BOARD? 731 00:30:23,000 --> 00:30:26,000 IF NOT, LET ME ON BEHALF OF MY 732 00:30:26,000 --> 00:30:31,120 CO-CHAIR PAT LORUSSO AND THE 733 00:30:31,120 --> 00:30:32,320 BOARD, THANK YOU FOR YOUR 734 00:30:32,320 --> 00:30:32,880 PRESENTATION. 735 00:30:32,880 --> 00:30:33,520 >>Dr. Bertagnolli: IT'S GREAT 736 00:30:33,520 --> 00:30:33,880 TO SEE YOU ALL. 737 00:30:33,880 --> 00:30:35,000 THANK YOU FOR BEING HERE. 738 00:30:35,000 --> 00:30:36,200 >>THANK YOU. 739 00:30:36,200 --> 00:30:39,040 AND I BELIEVE NOW WE NEED TO SIT 740 00:30:39,040 --> 00:30:40,800 TIGHT WHILE AV WILL SINUS OFF 741 00:30:40,800 --> 00:30:43,520 FROM THE VIDEO CAST SYSTEM. 742 00:30:43,520 --> 00:30:45,200 THE GOAL IS THAT WE DON'T HAVE 743 00:30:45,200 --> 00:30:46,640 TO RECONNECT BUT WE'LL SEE 744 00:30:46,640 --> 00:30:48,160 WHETHER IT WORKS. 745 00:30:48,160 --> 00:30:50,360 >>IF YOU GET DISCONNECTED, JUST 746 00:30:50,360 --> 00:30:51,400 CALL RIGHT BACK IN. 747 00:30:51,400 --> 00:30:52,000 >>YES. 748 00:30:52,000 --> 00:30:58,400 >>AND WE'LL TAKE ABOUT A -- 749 00:30:58,400 --> 00:31:01,040 WE'LL RECONVENE AT 11:40 THAT 750 00:31:01,040 --> 00:31:03,080 SHOULD GIVE TIME TO DISCONNECT 751 00:31:03,080 --> 00:31:04,040 AND TAKE A BREAK. 752 00:31:04,040 --> 00:31:07,280 >>OKAY. 753 00:31:07,280 --> 00:31:17,480 THANK YOU.